Articles

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy;Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy
Experimental Therapeutics IFOM-FIRC Institute of Molecular Oncology Foundation, Milan, Italy
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy;Faculty of Biotechnology, October University for Modern Sciences and Arts, 6th October City, Cairo, Egypt
Experimental Therapeutics IFOM-FIRC Institute of Molecular Oncology Foundation, Milan, Italy
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy;Department of Biosciences, University of Milan, Milan, Italy
Vol. 105 No. 8 (2020): August, 2020 https://doi.org/10.3324/haematol.2019.224501